Posted by Michael Wonder on 02 Oct 2025
TAHO Pharma announces submission of new drug application to the US FDA for TAH3311 – the world’s first apixaban oral dissolving film – represents a transformational advancement in anti-coagulant therapy
30 September 2025 - TAHO Pharmaceuticals today announced the submission of its new drug application to the US FDA for TAH3311, the world’s first apixaban oral dissolving film.
TAH3311 is an innovative formulation designed to improve the delivery of apixaban, a widely used anti-coagulant.
Read TAHO Pharmaceuticals press release
